Deep Track Capital, LP

$6.1B reported 13(f) long value · latest quarter 2026-03-31 · CIK 1856083 · EDGAR ↗

sum of disclosed values for 2026-03-31; 0 positions carry a NULL value and are excluded from the sum, surfaced here rather than folded away: $6.1B
ALL retained default holdings for this (filer, period), including NULL-value ones: 63
positions with no comparable holding in the prior quarter (kind new), 2026-03-31: 16
positions absent from this quarter's filing after being held last quarter (kind exit), 2026-03-31 — inferred from absence, not a sale record: 8

A quarter-end snapshot. Filed up to 45 days later, so this page is not current holdings and never a complete portfolio. what a 13F is — and is not ↓ methodology §13F ↗

Position changes — into 2026-03-31

by shares · Δ value · filing link · how changes are classified §

Position changes into quarter 2026-03-31
position matched across quarters by exact reported CUSIP over a registry gap — producer-reconciled identity, never a name match `identity_reconciled_by_cusip`	the reported share count is unchanged across the pair; this build's data classified the change from its reported value; builds from 2026-09-10 on read it as NO CHANGE `classified_by_value` · EXIT = absent this quarter: disposed, delisted, under confidential treatment, or reported instead by an affiliated manager — the filing does not say which · change not classifiable: value undisclosed on one side of the quarter pair, or neither shares nor value can classify it · NO CHANGE = the share count is identical in both quarters; the value moved only with price, so the row is mark-to-market and never an ADD or a TRIM (NEW / ADD / TRIM / EXIT / NO CHANGE) · NO PRIOR = this filer has no comparable holdings list for the previous quarter on record — a first filing under this registration, or a quarter reported inside an affiliated manager's filing — so the position is not called a new stake	derived by Public Filings from the published aggregate; NULL means the source did not disclose a usable value — never zero	reported unit changed across the pair (SH↔PRN); the share delta is withheld rather than fabricated `shares_unit_mismatch`	Prev value	Curr value	Prev shares	Curr shares
position key `pos:17626` · issuer key `iss:860` COM	ADD	+$22.4M	+538,241	$286M	$308M	2,800,000	3,338,241
position key `pos:10610` · issuer key `iss:1761` COM	ADD	+$6.6M	+595,966	$246M	$253M	3,004,034	3,600,000
position key `pos:11660` · issuer key `iss:1893` COM	ADD	+$65.3M	+300,000	$185M	$250M	4,000,000	4,300,000
position key `sid:sec:prov:862b191ccb923fc424f39385b48ce4f8` · issuer key `cusip6:86366E` SPONSORED ADS	ADD	−$79.7M	+168,066	$286M	$206M	4,111,782	4,279,848
position key `pos:13067` · issuer key `iss:210` COM	TRIM	−$24.1M	−50,000	$210M	$186M	1,150,000	1,100,000
position key `sid:sec:prov:233302be8852a126d4f3dc726082a4c4` · issuer key `cusip6:03753U` COM	TRIM	−$12.3M	−3,217,626	$195M	$182M	7,750,000	4,532,374
position key `sid:sec:prov:26fd673c04b9acd4e799cbdab734d215` · issuer key `cusip6:67576A` COM	ADD	+$68.8M	+11,615,868	$98.0M	$167M	8,070,414	19,686,282
position key `sid:sec:prov:c6f0567aff349dfe2dab4a6ee5ba8988` · issuer key `cusip6:92337R` CL A	ADD	+$22.3M	+1,284,932	$143M	$165M	2,821,135	4,106,067
position key `pos:16159` · issuer key `iss:94` COM	NEW	+$149M	+6,772,595	$0	$149M	—	6,772,595
position key `pos:11517` · issuer key `iss:1003` COM	ADD	+$11.9M	+250,000	$134M	$146M	1,700,000	1,950,000
position key `pos:13206` · issuer key `iss:1335` COM	NEW	+$141M	+1,376,324	$0	$141M	—	1,376,324
position key `pos:15525` · issuer key `iss:2023` SHS	ADD	+$71.0M	+1,590,323	$56.0M	$127M	2,000,000	3,590,323
position key `pos:17964` · issuer key `cusip6:152309` SPONSORED ADS	ADD	+$75.4M	+1,158,041	$50.0M	$125M	2,000,000	3,158,041
position key `sid:sec:prov:66a515f74f11d5e1caa284d2543264a2` · issuer key `cusip6:61559X` CLASS A ORD	ADD	+$58.7M	+1,798,792	$60.8M	$119M	4,610,071	6,408,863
position key `pos:15345` · issuer key `iss:1204` COM	TRIM	−$72.1M	−768,878	$176M	$104M	4,246,440	3,477,562
position key `pos:13812` · issuer key `iss:1378` COM	TRIM	+$34.3M	−127,307	$65.5M	$99.8M	2,161,510	2,034,203
position key `sid:sec:prov:48ac0f50c981e01f7c5af17d58a117cf` · issuer key `cusip6:67080M` COM	TRIM	−$35.1M	−691,211	$133M	$98.4M	7,036,455	6,345,244
position key `pos:16478` · issuer key `iss:814` SPONSORED ADS	NEW	+$98.3M	+3,663,250	$0	$98.3M	—	3,663,250
position key `pos:12465` · issuer key `iss:548` COM NEW	TRIM	−$121M	−1,962,678	$212M	$90.6M	3,336,998	1,374,320
position key `pos:12631` · issuer key `iss:843` COM	ADD	+$1.5M	+700,000	$87.5M	$89.0M	1,022,797	1,722,797
position key `sid:sec:prov:1910147dd0682cb840152de5838d5484` · issuer key `cusip6:55287L` COM	TRIM	−$20.2M	−492,221	$102M	$82.3M	3,249,790	2,757,569
position key `sid:sec:prov:b23dd6a0ecec2737a5c87e9c74cf430d` · issuer key `cusip6:055477` COM	ADD	+$36.8M	+1,448,496	$44.0M	$80.8M	2,614,004	4,062,500
position key `sid:sec:prov:88f799da4526ad1ae0a440740a6e9c1b` · issuer key `cusip6:20451W` SPONSORED ADS	ADD	+$16.6M	+4,827,173	$50.6M	$67.3M	7,334,323	12,161,496
position key `pos:11035` · issuer key `iss:266` COM	TRIM	−$71.7M	−1,150,000	$137M	$65.0M	2,300,000	1,150,000
position key `pos:14584` · issuer key `iss:311` COM	ADD	+$518K	+31,303	$62.0M	$62.5M	810,142	841,445
position key `pos:15541` · issuer key `iss:958` ADS	TRIM	−$11.3M	−72,094	$69.6M	$58.2M	2,003,978	1,931,884
position key `pos:11535` · issuer key `iss:1757` COM	ADD	+$35.8M	+295,438	$21.7M	$57.5M	2,454,562	2,750,000
position key `pos:16675` · issuer key `iss:563` COM SHS	NEW	+$56.7M	+3,000,000	$0	$56.7M	—	3,000,000
position key `pos:17472` · issuer key `cusip6:880881` COM	ADD	+$25.5M	+304,829	$31.1M	$56.6M	769,048	1,073,877
position key `sid:sec:prov:b6aaf2a1d9a7b3e3e2f1185e3325ec7d` · issuer key `cusip6:374163` COM	TRIM	+$4.3M	−790,993	$42.9M	$47.3M	32,511,271	31,720,278
position key `pos:13106` · issuer key `iss:14` COM	ADD	+$8.4M	+122,316	$37.7M	$46.1M	477,684	600,000
position key `pos:14932` · issuer key `iss:519` COM	ADD	−$18.7M	+1,000,000	$61.3M	$42.6M	5,274,076	6,274,076
position key `pos:12610` · issuer key `iss:183` COM SHS	NEW	+$42.5M	+12,000,000	$0	$42.5M	—	12,000,000
position key `sid:sec:prov:30f8f229420c7a82ec2ecf2f2f622045` · issuer key `cusip6:15117B` COM NEW	TRIM	−$10.9M	−616,759	$51.6M	$40.7M	1,900,738	1,283,979
position key `pos:17421` · issuer key `iss:475` COM	ADD	+$22.4M	+546,898	$16.1M	$38.5M	453,102	1,000,000
position key `sid:sec:prov:990effbc09610fc927e1edc54d252d9d` · issuer key `cusip6:221015` COM	NEW	+$36.5M	+2,491,539	$0	$36.5M	—	2,491,539
position key `pos:13703` · issuer key `iss:619` COM	TRIM	−$15.6M	−650,000	$51.8M	$36.3M	2,650,000	2,000,000
position key `sid:sec:prov:9c654c0b85e21e330a7ebfd2ced217c7` · issuer key `cusip6:834203` COM	ADD	−$10.2M	+78,710	$46.3M	$36.1M	1,000,000	1,078,710
position key `sid:sec:prov:d6ea93a81ffbe77fbd59d8ff01875a57` · issuer key `cusip6:00461U` COM	NEW	+$35.0M	+9,345,000	$0	$35.0M	—	9,345,000
position key `pos:14234` · issuer key `iss:1897` COMMON STOCK	NEW	+$31.6M	+500,000	$0	$31.6M	—	500,000
position key `sid:sec:prov:4b145c10f034612809a5ead021971789` · issuer key `cusip6:92790C` COM	TRIM	−$51.3M	−1,130,889	$78.6M	$27.3M	2,524,833	1,393,944
position key `sid:sec:prov:19b9675407eb505d5af586b26c66f53a` · issuer key `cusip6:98420X` COM NEW	ADD	+$6.1M	+1,325,874	$20.1M	$26.2M	5,013,661	6,339,535
position key `pos:11739` · issuer key `iss:1687` COM NEW	NEW	+$25.7M	+3,565,062	$0	$25.7M	—	3,565,062
position key `pos:13239` · issuer key `iss:142` COM	NEW	+$24.0M	+285,000	$0	$24.0M	—	285,000
position key `sid:sec:prov:44dcd89ab4e3fa904b2bfbfadeb83d25` · issuer key `cusip6:50127T` COM	NEW	+$21.5M	+2,643,542	$0	$21.5M	—	2,643,542
position key `sid:sec:prov:310355a827423f86fff2dece8e909dcb` · issuer key `cusip6:15673T` COM	NEW	+$21.4M	+9,487,745	$0	$21.4M	—	9,487,745
position key `sid:sec:prov:fbdfb263adbfc86bd605b695db4205d4` · issuer key `cusip6:07373V` COM	NEW	+$19.6M	+820,765	$0	$19.6M	—	820,765
position key `sid:sec:prov:67b21944302e27e04909ebe77fb217b9` · issuer key `cusip6:71535D` COM	NEW	+$19.1M	+3,000,000	$0	$19.1M	—	3,000,000
position key `sid:sec:prov:7f79da9ff584753bfd1b9acc24c00236` · issuer key `cusip6:47103J` COM	ADD	+$15.3M	+1,097,701	$1.2M	$16.5M	89,589	1,187,290
position key `sid:sec:prov:9cf954fd781de1b6ee57fd4c3c78fde3` · issuer key `cusip6:74346M` COM SHS	NEW	+$10.6M	+835,655	$0	$10.6M	—	835,655
position key `sid:sec:prov:36f6260da0bf69546f0e601e6d5bafdc` · issuer key `cusip6:46124U` ADS	ADD	+$4.5M	+732,453	$2.3M	$6.8M	490,000	1,222,453
position key `sid:sec:prov:853ca021ff04669801b685877f2dabbb` · issuer key `cusip6:517125` COM	NEW	+$6.8M	+1,500,000	$0	$6.8M	—	1,500,000
position key `sid:sec:prov:f9e727b82dcd40853324f87329f6f70c` · issuer key `cusip6:23256X` COM NEW	TRIM	−$8.9M	−541,118	$15.2M	$6.3M	1,854,255	1,313,137
pos:12517	EXIT‡e	−$16.4M	−366,435	$16.4M	$0	366,435	—
pos:13686 CALL	EXIT‡e	−$5.6M	−500,000	$5.6M	$0	500,000	—
sid:sec:prov:0983c227d7f489fadce1abda0a417532	EXIT‡e	−$3.7M	−110,448	$3.7M	$0	110,448	—
sid:sec:prov:3044f98940a2897deb445091c04637d0	EXIT‡e	−$22.4M	−1,676,540	$22.4M	$0	1,676,540	—
sid:sec:prov:6a1de202689437ba5ea3d3a29fa60708	EXIT‡e	−$242M	−15,726,349	$242M	$0	15,726,349	—
sid:sec:prov:7cea07f55574bfdadadb6c74621338ac	EXIT‡e	−$19.1M	−4,677,289	$19.1M	$0	4,677,289	—
sid:sec:prov:8416c67ffd3651f6a5f8d9788c0f2e31	EXIT‡e	−$6.2M	−95,408	$6.2M	$0	95,408	—
sid:sec:prov:aa9011438474f45ca7c81a2864931aa4	EXIT‡e	−$49.5K	−34,852	$49.5K	$0	34,852	—

Flags: no row carries a flag.

1–20 of the 61 changes on this page

Mark-to-market only (no share change) · 10

Positions whose share count is identical in both quarters; the value changed with price, not with a decision.

Positions held with no share change into quarter 2026-03-31
position matched across quarters by exact reported CUSIP over a registry gap — producer-reconciled identity, never a name match `identity_reconciled_by_cusip`	the reported share count is unchanged across the pair; this build's data classified the change from its reported value; builds from 2026-09-10 on read it as NO CHANGE `classified_by_value` · EXIT = absent this quarter: disposed, delisted, under confidential treatment, or reported instead by an affiliated manager — the filing does not say which · change not classifiable: value undisclosed on one side of the quarter pair, or neither shares nor value can classify it · NO CHANGE = the share count is identical in both quarters; the value moved only with price, so the row is mark-to-market and never an ADD or a TRIM (NEW / ADD / TRIM / EXIT / NO CHANGE) · NO PRIOR = this filer has no comparable holdings list for the previous quarter on record — a first filing under this registration, or a quarter reported inside an affiliated manager's filing — so the position is not called a new stake	derived by Public Filings from the published aggregate; NULL means the source did not disclose a usable value — never zero	Prev value	Curr value	Prev shares	Curr shares
position key `pos:10141` · issuer key `iss:1602` STATE STREET SPD PUT	NO CHANGE	+$58.0M	$1.2B	$1.3B	10,000,000	10,000,000
position key `sid:sec:prov:c0680e314bfe2d1131f5c3d642c67920` · issuer key `cusip6:45258J` COM	NO CHANGE	−$6.7M	$293M	$286M	11,526,971	11,526,971
position key `sid:sec:prov:be515631054470e2500985b7cc1d1245` · issuer key `cusip6:50180M` COM SHS	NO CHANGE	+$8.0M	$74.6M	$82.7M	3,352,804	3,352,804
position key `pos:13163` · issuer key `cusip6:92337C` COM NEW	NO CHANGE	−$13.9M	$44.3M	$30.4M	5,740,850	5,740,850
position key `sid:sec:prov:c58e51841f60c26aab31f70d6e4eabc3` · issuer key `cusip6:29286M` COM	NO CHANGE	−$9.7M	$39.5M	$29.8M	4,377,572	4,377,572
position key `sid:sec:prov:9f0cd92ab05ebfeeed30ea3f0847daef` · issuer key `cusip6:29251M` COM	NO CHANGE	−$6.1M	$30.9M	$24.7M	1,956,867	1,956,867
position key `sid:sec:prov:1e37f227d26a900c417273e355bd6875` · issuer key `cusip6:21077P` COM	NO CHANGE	+$8.5M	$10.9M	$19.4M	7,419,355	7,419,355
position key `pos:16706` · issuer key `iss:2081` COM	NO CHANGE	+$3.0M	$5.4M	$8.3M	453,686	453,686
position key `pos:18210` · issuer key `iss:263` CL A	NO CHANGE	−$145K	$4.1M	$3.9M	50,000	50,000
position key `sid:sec:prov:c8979a8455f9af85be7efdcf54e29bb5` · issuer key `cusip6:01626L` COM NEW	NO CHANGE	−$839K	$4.1M	$3.3M	444,110	444,110

Flags: no row carries a flag.

Newest filing in this build: 2026-07-31. Per-row filing dates are on each receipt.

Truncated by Public Filings. Changes compare every position with a security identifier, new and exited included; holdings without one are counted, not compared. methodology §13F ↗

Reported positions — 2026-03-31

1–63 of 63 positions · $6.1B disclosed value over 63 rows · 0 undisclosed-value rows

View

This build carries one quarter for this manager: 2026-03-31. Notable managers carry four published quarters, others two.

Positions Deep Track Capital, LP reported for the quarter ended 2026-03-31, as that filer reported them
This list carries reported issuer names and security identities, without a dated ticker mapping. Symbols are not inferred from names.	a position composed from a base filing plus NEW-HOLDINGS amendments keeps every source row here; the composition's latest filed date is the one shown served from this build's published holdings (derived from the filer's own reported rows); every row resolves to its filing	value undisclosed on the filing: retained and counted, excluded from sums, never shown as $0	Shares	Wt
—	SPDR SERIES TRUST · STATE STREET SPD · PUT CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$1.3B	10,000,000	20.9%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	GUARDANT HEALTH INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$308M	3,338,241	5.0%
—	IMMUNOVANT INC · COM CUSIP 45258J102 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$286M	11,526,971	4.7%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	TARSUS PHARMACEUTICALS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$253M	3,600,000	4.1%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	VAXCYTE INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$250M	4,300,000	4.1%
—	STRUCTURE THERAPEUTICS INC · SPONSORED ADS CUSIP 86366E106 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$206M	4,279,848	3.4%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	AXSOME THERAPEUTICS INC. · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$186M	1,100,000	3.0%
—	APELLIS PHARMACEUTICALS INC · COM CUSIP 03753U106 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$182M	4,532,374	3.0%
—	OCULAR THERAPEUTIX INC · COM CUSIP 67576A100 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$167M	19,686,282	2.7%
—	VERA THERAPEUTICS INC · CL A CUSIP 92337R101 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$165M	4,106,067	2.7%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	ALUMIS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$149M	6,772,595	2.4%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	IONIS PHARMACEUTICALS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$146M	1,950,000	2.4%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	NUVALENT INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$141M	1,376,324	2.3%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	ALKERMES PLC · SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$127M	3,590,323	2.1%
—	CENTESSA PHARMACEUTICALS PLC · SPONSORED ADS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$125M	3,158,041	2.0%
—	MOONLAKE IMMUNOTHERAPEUTICS · CLASS A ORD CUSIP 61559X104 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$119M	6,408,863	2.0%
—	MAZE THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$104M	3,477,562	1.7%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	ORUKA THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$99.8M	2,034,203	1.6%
—	NURIX THERAPEUTICS INC · COM CUSIP 67080M103 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$98.4M	6,345,244	1.6%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	GENMAB A/S · SPONSORED ADS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$98.3M	3,663,250	1.6%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	CYTOKINETICS INC · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$90.6M	1,374,320	1.5%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	GRAIL INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$89.0M	1,722,797	1.5%
—	LB PHARMACEUTICALS INC · COM SHS CUSIP 50180M108 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$82.7M	3,352,804	1.4%
—	MBX BIOSCIENCES INC · COM CUSIP 55287L101 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$82.3M	2,757,569	1.3%
—	BICARA THERAPEUTICS INC · COM CUSIP 055477103 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$80.8M	4,062,500	1.3%
—	COMPASS PATHWAYS PLC · SPONSORED ADS CUSIP 20451W101 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$67.3M	12,161,496	1.1%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	BIOMARIN PHARMACEUTICAL INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$65.0M	1,150,000	1.1%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	BRIDGEBIO PHARMA INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$62.5M	841,445	1.0%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	IMMUNOCORE HLDGS PLC · ADS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$58.2M	1,931,884	1.0%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	TANGO THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$57.5M	2,750,000	0.9%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	DEFINIUM THERAPEUTICS INC · COM SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$56.7M	3,000,000	0.9%
—	TERNS PHARMACEUTICALS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$56.6M	1,073,877	0.9%
—	GERON CORP · COM CUSIP 374163103 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$47.3M	31,720,278	0.8%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	ANI PHARMACEUTICALS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$46.1M	600,000	0.8%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	CORMEDIX INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$42.6M	6,274,076	0.7%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	ATAIBECKLEY INC · COM SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$42.5M	12,000,000	0.7%
—	CELLDEX THERAPEUTICS INC NEW · COM NEW CUSIP 15117B202 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$40.7M	1,283,979	0.7%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	COGENT BIOSCIENCES INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$38.5M	1,000,000	0.6%
—	CORVUS PHARMACEUTICALS INC · COM CUSIP 221015100 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$36.5M	2,491,539	0.6%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	DYNE THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$36.3M	2,000,000	0.6%
—	SOLENO THERAPEUTICS INC · COM CUSIP 834203309 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$36.1M	1,078,710	0.6%
—	ACLARIS THERAPEUTICS INC · COM CUSIP 00461U105 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$35.0M	9,345,000	0.6%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	VERADERMICS INC · COMMON STOCK CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$31.6M	500,000	0.5%
—	VERASTEM INC · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$30.4M	5,740,850	0.5%
—	ENGENE HOLDINGS INC · COM CUSIP 29286M105 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$29.8M	4,377,572	0.5%
—	VIRIDIAN THERAPEUTICS INC · COM CUSIP 92790C104 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$27.3M	1,393,944	0.4%
—	X4 PHARMACEUTICALS INC · COM NEW CUSIP 98420X202 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$26.2M	6,339,535	0.4%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	SOLID BIOSCIENCES INC · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$25.7M	3,565,062	0.4%
—	ENANTA PHARMACEUTICALS INC · COM CUSIP 29251M106 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$24.7M	1,956,867	0.4%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	APOGEE THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$24.0M	285,000	0.4%
—	KURA ONCOLOGY INC · COM CUSIP 50127T109 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$21.5M	2,643,542	0.4%
—	CENTURY THERAPEUTICS INC · COM CUSIP 15673T100 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$21.4M	9,487,745	0.4%
—	BEAM THERAPEUTICS INC · COM CUSIP 07373V105 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$19.6M	820,765	0.3%
—	CONTEXT THERAPEUTICS INC · COM CUSIP 21077P108 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$19.4M	7,419,355	0.3%
—	PERSONALIS INC · COM CUSIP 71535D106 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$19.1M	3,000,000	0.3%
—	JANUX THERAPEUTICS INC · COM CUSIP 47103J105 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$16.5M	1,187,290	0.3%
—	PROMIS NEUROSCIENCES INC · COM SHS CUSIP 74346M505 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$10.6M	835,655	0.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	CRESCENT BIOPHARMA INC. · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$8.3M	453,686	0.1%
—	INVENTIVA SA · ADS CUSIP 46124U107 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$6.8M	1,222,453	0.1%
—	LARIMAR THERAPEUTICS INC · COM CUSIP 517125100 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$6.8M	1,500,000	0.1%
—	CYBIN INC · COM NEW CUSIP 23256X407 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$6.3M	1,313,137	0.1%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	BILLIONTOONE INC · CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$3.9M	50,000	0.1%
—	ALIGOS THERAPEUTICS INC · COM NEW CUSIP 01626L204 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$3.3M	444,110	0.1%

1–20 of 63 positions

Change kind and share change are in Position changes above; Congress overlap is planned.

One line per issuer, largest first; a row with no issuer key stands on its own line. Open a line for its rows as this filer reported them. The list holds every row this filer reported for the quarter. Issuer totals on the holders pages count each manager's own report once; that never removes a row here. how positions are grouped ↗

Book shape

2026-03-31 · concentration · vs tracked median · tick = median

Top-25 concentration: 80.3%above median 80.0%
Concentration index: 623 bpsabove median 446 bps
Positions with value: 63 / 63median book 97.5 positions

Concentration uses reported 13F long value, not total assets. The index is withheld when any position lacks a value. Medians are over the 8,748 tracked filers with a 2026-03-31 book; the index median over the 8,662 with a complete book.

holdings whose <value> did not parse — retained and counted, never zero-filled: 0 · share of the period's disclosed value held in the top-N positions; denominator is reported 13F value, not total assets: 80.3% · integer Herfindahl–Hirschman index in basis points over disclosed position values: 623 · QoQ moves: 71

Filing history

AVAILABLE QUARTERS

Available filing periods
Period	Source
2026-03-31	EDGAR ↗

PLANNED sector rotation · Congress overlap · signals for this filer

Complete source filings on SEC EDGAR

The complete filing on EDGAR.

The position list above is served from the published Public Filings build, each position as this filer reported it; where the page cannot embed every reported row, the list says how many it leaves out. This block is provenance, not a substitute: the filing itself is the record, and it is one click away. Public Filings decided on 2026-08-01 to serve this list from its published build; filings newer than this build are on EDGAR.

Open Deep Track Capital, LP's 13F filings on SEC EDGAR ↗

Notes on this data

Reported positions

Quarter-end holdings as filed

Explore the full published position list and its source filing. This record excludes the manager’s cash, shorts and non-13(f) assets.

Share changes

Compare consecutive quarters

Position changes retain the producer’s classification and comparability flags. Share counts and reported values describe different changes.

Coverage

A snapshot, not current holdings

Use the quarter selector to inspect available periods. Unknown values stay unknown and each table states its coverage.

A 13F is a quarterly, long-only snapshot filed up to 45 days late — not current holdings. what a 13F covers ↗

13F reports cover LONG positions in Section 13(f) securities (US exchange-traded equities plus reportable options, warrants, certain convertibles) held by managers with at least $100M in such securities — so managers below that threshold are absent entirely. No short positions, no cash, no non-13(f) assets — not a full portfolio, and not a census of institutional ownership.

Positions are quarter-end snapshots filed up to 45 days late — not current holdings. A position may have been changed or closed before you ever see it, and is older still by however long ago that quarter ended.

Values are the manager's stated market value at quarter-end in era-dependent units (whole dollars for form versions effective 2023-01-03 onward, thousands before), normalized here to whole dollars with unit_basis carried on every record.

Affiliated managers may report the same position (otherManager), so one position can appear under more than one filer.

Positions under confidential treatment may be omitted until a later amendment discloses them.

These are disclosures, not investment advice (ARCHITECTURE.md §5.2 / M2-CONTRACT §5).